| 1 |
NCT03015636 |
Active, not recruiting |
BSIP - Better Sleep in Psychiatric Care - ADHD. |
|
- Behavioral: Adjusted CBT-i for ADHD
- Other: Treatment as Usual
|
Interventional
|
Not Applicable |
- Karolinska Institutet
- Department of ADHD, Northern Stockholm Psychiatry
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Investigator)
- Primary Purpose: Treatment
|
- Insomnia Severity Index
- Actigraphy
- Sleep diary
|
50 |
All |
18 Years and older (Adult, Older Adult) |
NCT03015636 |
2016/1988-31 |
BSIP-ADHD |
December 2016 |
June 2018 |
June 2018 |
January 10, 2017 |
March 12, 2018 |
|
- Department of ADHD, Northern Stockholm Psychiatry
Stockholm, Sweden
|
|
| 2 |
NCT03565250 |
Recruiting |
A Study of Identity Building in Children With ADHD |
- Attention Deficit Hyperactivity Disorder
|
- Other: self understanding interview
|
Interventional
|
Not Applicable |
- University Hospital, Caen
- Institut National de la Santé Et de la Recherche Médicale, France
- Ecole Pratique des Hautes Etudes
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Identity building
- • Intensity score of ADHD
- Self esteem
- (and 5 more...)
|
40 |
All |
8 Years to 12 Years (Child) |
NCT03565250 |
17-011 |
SID-ADHD |
July 20, 2018 |
August 4, 2020 |
December 31, 2020 |
June 21, 2018 |
July 13, 2018 |
|
- Caen University Hospital
Caen, France
|
|
| 3 |
NCT03620344 |
Recruiting |
ADHD/Me Bibliotherapy Study |
- Attention Deficit Hyperactivity Disorder
|
- Other: ADH-Me Book and ADHD Informational Brochure
- Other: ADHD Informational Brochure Only
|
Interventional
|
Not Applicable |
- Children's Hospital Medical Center, Cincinnati
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- ADHD Knowledge and Opinion Survey - Revised
- Decision-Making Involvement Scale - Parent Report
- Decision-Making Involvement Scale - Youth Report
|
60 |
All |
7 Years to 10 Years (Child) |
NCT03620344 |
2017-4815 |
|
August 13, 2018 |
June 30, 2019 |
June 30, 2019 |
August 8, 2018 |
August 8, 2018 |
|
- Center for ADHD, Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio, United States
|
|
| 4 |
NCT03447223 |
Not yet recruiting |
Gut Microbiome and Serum Metabolome Alterations in ADHD Patients |
|
|
Observational
|
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Retrospective
|
- ADHD-associated gut microbial species alterations
- ADHD-associated circulating metabolites alterations
|
400 |
All |
3 Years to 15 Years (Child) |
NCT03447223 |
KY20182002-1 |
ADHD |
February 28, 2018 |
February 27, 2020 |
February 27, 2020 |
February 27, 2018 |
March 1, 2018 |
|
|
|
| 5 |
NCT03628781 |
Not yet recruiting |
Improving ADHD Behavioral Care |
|
- Other: Behavioral tools integrated within mehealth for ADHD software
- Other: mehealth for ADHD
|
Interventional
|
Not Applicable |
- Children's Hospital Medical Center, Cincinnati
- Agency for Healthcare Research and Quality (AHRQ)
|
Other / U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Rates of behavioral treatment
- Quality of behavioral treatments
- Children's impairment levels
- Family satisfaction with ADHD treatment
|
150 |
All |
5 Years to 12 Years (Child) |
NCT03628781 |
R18HS024690 |
|
August 21, 2018 |
August 31, 2020 |
August 31, 2020 |
August 14, 2018 |
August 15, 2018 |
|
|
|
| 6 |
NCT03515135 |
Enrolling by invitation |
A Randomized Controlled Study of MEFP for Preschool Children With ADHD |
|
- Behavioral: Metacognitive Executive Function Training
|
Interventional
|
Not Applicable |
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Health Services Research
|
- The executive function of preschool child of ADHD
- The executive function in real life of preschool child of ADHD
- The ADHD symptoms of child
|
80 |
All |
4 Years to 6 Years (Child) |
NCT03515135 |
XH-17-003 |
|
June 1, 2017 |
December 2018 |
December 2018 |
May 3, 2018 |
May 10, 2018 |
|
- Xinhua Hospital
Shanghai, China
|
|
| 7 |
NCT02716324 |
Active, not recruiting |
Communication to Improve Shared Decision-Making in ADHD |
- Attention-Deficit/Hyperactivity Disorder
|
- Behavioral: Care Manager
- Other: ADHD Portal
|
Interventional
|
Not Applicable |
- Children's Hospital of Philadelphia
- Patient-Centered Outcomes Research Institute
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Vanderbilt Parent Rating Scales (VPRS)
- Change in Vanderbilt Teacher Rating Scales (VTRS)
- Change in Goal Attainment Scale (GAS)
- (and 7 more...)
|
303 |
All |
5 Years to 12 Years (Child) |
NCT02716324 |
IRB 15-012456 |
ADHD-Link |
March 2016 |
July 30, 2018 |
October 2018 |
March 23, 2016 |
August 8, 2018 |
|
- The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
|
|
| 8 |
NCT02463396 |
Completed |
Mindfulness Training in Adults With ADHD |
|
- Behavioral: MBCT for ADHD
|
Interventional
|
Not Applicable |
- Radboud University
- ZonMw: The Netherlands Organisation for Health Research and Development
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change from baseline in investigator-rated ADHD symptoms
- Change from baseline in self-reported ADHD symptoms
- Change from baseline in executive functioning
- (and 5 more...)
|
120 |
All |
18 Years and older (Adult, Older Adult) |
NCT02463396 |
NL48776.091.14
837001501 |
|
September 2014 |
September 2016 |
September 2017 |
June 4, 2015 |
April 19, 2018 |
|
- Radboudumc
Nijmegen, Gelderland, Netherlands
|
|
| 9 |
NCT03203928 |
Completed |
Effectiveness of a Tailored Occupational Therapy Intervention for Women With ADHD |
- Attention Deficit Hyperactivity Disorder
|
- Behavioral: Occupational Therapy Intervention for Women with ADHD
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Difference in Score on World Health Organization Adult ADHD Self-Report Scale between pre- and post-intervention
- Difference in Score on Perceived Stress Scale between pre- and post-intervention
- Difference in Score on Canadian Occupational Performance Measure
|
23 |
Female |
21 Years to 55 Years (Adult) |
NCT03203928 |
AAAR4416 |
|
September 15, 2017 |
January 10, 2018 |
January 10, 2018 |
June 29, 2017 |
July 17, 2018 |
|
- Columbia University Medical Center
New York, New York, United States
|
|
| 10 |
NCT03436017 |
Recruiting |
Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children |
|
- Other: Metabolomic approach
|
Observational
|
|
- University Hospital, Tours
|
Other |
- Observational Model: Other
- Time Perspective: Prospective
|
- ADHD metabolomic's signature of blood
- ADHD metabolomic's signature of urine
|
80 |
All |
6 Years to 15 Years (Child) |
NCT03436017 |
RIPH3-RNI17/METHADA |
METHADA |
November 7, 2017 |
November 2020 |
November 2020 |
February 16, 2018 |
February 16, 2018 |
|
- University Hospital TOURS
Tours, France
|
|
| 11 |
NCT03220308 |
Recruiting |
Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting |
- Attention Deficit Hyperactivity Disorder
|
- Other: MYmind mindfulness training
- Other: Care-as-usual for children (8-16 years old) with ADHD
|
Interventional
|
Not Applicable |
- Karakter Kinder- en Jeugdpsychiatrie
- Fonds Psychische Gezondheid
- European Commission
- (and 3 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change from Baseline in parent-rated self-control of the child
- Change from Baseline in parent-rated behaviour problems of the child
- Change from Baseline in parent-rated autistic social impairment of the child
- (and 20 more...)
|
100 |
All |
8 Years to 16 Years (Child) |
NCT03220308 |
20016 MIND |
MindChamp |
February 18, 2016 |
July 2018 |
December 2018 |
July 18, 2017 |
September 7, 2017 |
|
- Karakter, Expertisecentrum voor kinder- en jeugdpsychiatrie
Arnhem, Gelderland, Netherlands - Karakter, Expertisecentrum voor kinder- en jeugdpsychiatrie
Ede, Gelderland, Netherlands - Karakter, Expertisecentrum voor kinder- en jeugdpsychiatrie
Nijmegen, Gelderland, Netherlands
|
|
| 12 |
NCT02674633 |
Completed |
Software Treatment for Actively Reducing Severity of ADHD |
- Attention Deficit Disorder With Hyperactivity
|
|
Interventional
|
Not Applicable |
- Akili Interactive Labs, Inc.
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in the Attention Performance Index (API), an overall composite score, from the Test of Variables of Attention (TOVA 8)
- Change in The Cambridge Neuropsychological Test Automated Battery (CANTAB) - Spatial Working Memory, subtest
- Change in the ADHD symptoms as reported on the clinician-rated Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS), subscale and total scale
- (and 4 more...)
|
348 |
All |
8 Years to 12 Years (Child) |
NCT02674633 |
Akili-001R |
STARS-ADHD |
May 2016 |
July 31, 2017 |
August 31, 2017 |
February 4, 2016 |
August 27, 2018 |
|
- Harmonex Neuroscience Research
Dothan, Alabama, United States - Melmed Center
Scottsdale, Arizona, United States - Avida, Inc.
Newport Beach, California, United States - (and 17 more...)
|
|
| 13 |
NCT02391428 |
Unknown † |
The Correlation Between Blood omega3 and ADHD |
- Attention Deficit Hyperactivity Disorder (ADHD)
|
- Procedure: blood test
- Dietary Supplement: omega3 capsules
|
Interventional
|
Early Phase 1 |
- Ayelet Omer Armon
- Ziv Hospital
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Investigator)
- Primary Purpose: Supportive Care
|
- blood omega3
- ADHD Symptoms
|
60 |
All |
6 Years to 14 Years (Child) |
NCT02391428 |
ZIV-0019-14
Ziv |
|
April 2015 |
September 2015 |
April 2016 |
March 18, 2015 |
March 19, 2015 |
|
|
|
| 14 |
NCT02828644 |
Completed |
Software Treatment for Actively Reducing Severity of ADHD - Follow Up |
- Attention Deficit Disorder With Hyperactivity
|
|
Interventional
|
Not Applicable |
- Akili Interactive Labs, Inc.
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Assess sustained effects in attention from end-of-treatment (Follow-Up Day 0) to Follow-Up Day 28 within groups that were previously randomized to receive 4 weeks of digital therapy
- Assess sustained effects in attention from end-of-treatment (Follow-Up Day 0) to Follow-Up Day 28 across groups that were previously randomized to receive 4 weeks of digital therapy
|
330 |
All |
8 Years to 12 Years (Child) |
NCT02828644 |
Akili-001R-FollowUp |
STARS-ADHD2 |
August 2016 |
December 2017 |
February 2018 |
July 11, 2016 |
March 23, 2018 |
|
- Melmed Center
Scottsdale, Arizona, United States - Avida, Inc.
Newport Beach, California, United States - University of California Davis MIND Institute
Sacramento, California, United States - (and 12 more...)
|
|
| 15 |
NCT02155608 |
Active, not recruiting |
Trigeminal Nerve Stimulation for ADHD |
- Attention Deficit Hyperactivity Disorder (ADHD)
|
- Device: Active TNS
- Device: Sham TNS
|
Interventional
|
Not Applicable |
- University of California, Los Angeles
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- ADHD-IV Rating Scale (ADHD-RS)
- Height
- Weight
- (and 13 more...)
|
62 |
All |
8 Years to 12 Years (Child) |
NCT02155608 |
NIMH R34MH101282
R34MH101282 |
TNS for ADHD |
December 2014 |
May 30, 2018 |
May 30, 2018 |
June 4, 2014 |
November 13, 2017 |
|
- UCLA Semel Institute
Los Angeles, California, United States
|
|
| 16 |
NCT02145793 |
Completed |
Exploring the Group Visit Model for Pediatric ADHD Management in the Medical Home |
|
- Behavioral: ADHD Group Curriculum
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Number of clinic visits during study period
- Parent-rated ADHD symptoms
- Child functioning at home
- (and 9 more...)
|
56 |
All |
6 Years to 18 Years (Child, Adult) |
NCT02145793 |
1204008526 |
|
June 2012 |
October 2013 |
November 2013 |
May 23, 2014 |
May 26, 2014 |
|
- General Pediatrics Clinic Medical Service Area 1 in Riley Hospital for Children at IU Health
Indianapolis, Indiana, United States
|
|
| 17 |
NCT01651169 |
Unknown † |
Methylphenidate on Intracortical Inhibition in Methamphetamine Abusers Attention Deficit Hyperactivity Disorder (ADHD) |
- Attention Deficit Hyperactivity Disorder
|
- Other: methylphenidate tablets and Inter-stimulus Intervals (ISI)
|
Interventional
|
Not Applicable |
- Tehran University of Medical Sciences
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
|
- Conners ADHD Rating Scale
- Change of Motor Evoked Potential (MEP)
|
30 |
All |
18 Years to 70 Years (Adult, Older Adult) |
NCT01651169 |
90-04-49-16359 |
ADHD |
September 2012 |
November 2015 |
March 2016 |
July 26, 2012 |
November 18, 2014 |
|
- Javad Alaghband-rad
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
|
|
| 18 |
NCT03663179 |
Recruiting
New |
Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD) |
- Attention Deficit Disorder With Hyperactivity (ADHD)
|
- Device: Transcranial Magnetic Stimulation (TMS)
- Device: Sham Transcranial Magnetic Stimulation (Sham TMS)
|
Interventional
|
Not Applicable |
- University of Pennsylvania
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in performance on Conners Adult ADHD Rating Scale - Self-Report: Long Version (ADHD symptoms)
- Change in performance on Conners Continuous Performance Task (sustained attention)
|
95 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT03663179 |
826586 |
|
January 2017 |
December 2018 |
June 2019 |
September 10, 2018 |
September 10, 2018 |
|
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
|
|
| 19 |
NCT02105142 |
Completed |
Comparative Effectiveness of Primary Care-based Interventions for Pediatric ADHD |
- Attention Deficit Hyperactivity Disorder
|
- Behavioral: ADHD Group Visits
- Behavioral: ADHD Group Visits plus Online Discussion Portal
- Behavioral: Computer Decision Support
|
Interventional
|
Not Applicable |
- Indiana University
- Agency for Healthcare Research and Quality (AHRQ)
|
Other / U.S. Fed |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Change in Vanderbilt ADHD Rating Scale scores
- Change in scores for pediatric quality of life
- Change in score of multidimensional scale of perceived social support scale
- (and 3 more...)
|
81 |
All |
6 Years to 12 Years (Child) |
NCT02105142 |
1305011436 |
|
April 2014 |
September 2015 |
September 2015 |
April 7, 2014 |
November 9, 2015 |
|
- General Pediatrics Clinic Medical Service Area 1 in Riley Hospital for Children at IU Health
Indianapolis, Indiana, United States - Eskenazi Health Center-Blackburn
Indianapolis, Indiana, United States - Eskenazi Health Center- Forest Manor
Indianapolis, Indiana, United States - (and 2 more...)
|
|
| 20 |
NCT03563573 |
Enrolling by invitation |
Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective |
|
- Drug: Potassium Gluconate Oral Capsule
- Drug: Placebo oral capsule
|
Interventional
|
Phase 1
Phase 2 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Prevalence of lidocaine ineffectiveness in those with ADHD
- Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
- Other discomforts
- (and 3 more...)
|
100 |
All |
13 Years to 49 Years (Child, Adult) |
NCT03563573 |
2017-01A |
|
July 1, 2018 |
November 4, 2018 |
December 31, 2018 |
June 20, 2018 |
June 20, 2018 |
|
- Clinical Research Center of New Jersey (CRCNJ)
Voorhees, New Jersey, United States
|
|
| 21 |
NCT02094612 |
Terminated
Has Results |
Effectiveness of the Quotient® ADHD Assessment in a System of Care |
- Attention Deficit and Disruptive Behavior Disorders
- Attention Deficit Disorder With Hyperactivity
|
- Device: Quotient®
- Behavioral: Usual Clinic ADHD Care
|
Interventional
|
Not Applicable |
- Kaiser Permanente
- Pearson/Clinical Assessment
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Number of Participants With 25% Reduction in SNAP Scores
- ADHD Symptomatology
- Academic Performance
- (and 4 more...)
|
207 |
All |
6 Years to 12 Years (Child) |
NCT02094612 |
CN-13-1692-H
Quotient ADHD |
|
March 2014 |
August 2015 |
August 2015 |
March 24, 2014 |
July 17, 2017 |
July 17, 2017 |
- Kaiser Permanente, Folsom
Folsom, California, United States - Kaiser Permanente, Roseville
Roseville, California, United States - Kaiser Permanente, Walnut Creek Medical Center
Walnut Creek, California, United States
|
|
| 22 |
NCT01308450 |
Completed
Has Results |
Adult Normative Performance of the Quotient ADHD System |
|
|
Observational
|
|
- BioBehavioral Diagnostics Company
|
Industry |
- Observational Model: Case-Only
- Time Perspective: Cross-Sectional
|
- Well-screened, Non-ADHD Controls to Augment the Existing Adolescent and Adult Database Thus Expanding the Normative Reference Range of Performance of the Quotient® Adolescent and Adult Version Test.
|
300 |
All |
15 Years to 55 Years (Child, Adult) |
NCT01308450 |
BBD0111 |
ADHD |
March 2011 |
June 2011 |
June 2011 |
March 4, 2011 |
November 27, 2013 |
October 30, 2013 |
- The Focus Center
Clinton, Utah, United States
|
|
| 23 |
NCT02824796 |
Recruiting |
Group Training for Parents Whose Children Suffer From ADHD and Comorbidity Using a Behavioral-Dynamic Approach |
|
- Behavioral: Schema Parent Behavioral Training
- Behavioral: Parent Behavioral Training
|
Interventional
|
Not Applicable |
- Assuta Hospital Systems
- Tel Aviv University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Change from baseline in parent-teacher-rated ADHD symptoms
- Dropout rate
- Change from baseline in parent-teacher-rated Comorbidities symptoms
|
140 |
All |
6 Years to 12 Years (Child) |
NCT02824796 |
2015096 |
SPBT |
January 2017 |
July 2019 |
July 2020 |
July 7, 2016 |
July 6, 2018 |
|
- Mental Health Children and Adolescent Clinic, Maccabi Health Services
Natanya, Israel
|
|
| 24 |
NCT01351064 |
Completed
Has Results |
Using Computers to Assist in the Diagnosis and Treatment of Attention-deficit/Hyperactivity Disorder (ADHD) |
- Attention Deficit Hyperactivity Disorder
|
|
Interventional
|
Not Applicable |
- Indiana University
- National Library of Medicine (NLM)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Investigator)
- Primary Purpose: Health Services Research
|
- Number of Children Diagnosed With ADHD With Structured Diagnostic Assessment
- Percent of Patients Receiving ADHD Care Component
|
84 |
All |
5 Years to 12 Years (Child) |
NCT01351064 |
CHICA_ADHD_Study
R01LM010031 |
|
July 2010 |
July 2012 |
July 2012 |
May 10, 2011 |
January 25, 2016 |
December 18, 2015 |
- Children's Health Services Research
Indianapolis, Indiana, United States
|
|
| 25 |
NCT01659164 |
Completed |
Psychological Treatment for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
|
- Behavioral: Group treatment for adults with ADHD
|
Interventional
|
Not Applicable |
- Karolinska Institutet
- Stockholm County Council, Sweden
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change (from baseline) in ASRS- v 1.1
- Change (from baseline) in ADHD Rating Scale
- Change (from baseline) in EQ-5D
- (and 5 more...)
|
18 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT01659164 |
2012/333-31 |
|
August 2012 |
June 2014 |
June 2014 |
August 7, 2012 |
April 3, 2015 |
|
- Internetpsykiatrienheten, Psykiatri Sydväst, SLSO
Stockholm, Sweden
|
|
| 26 |
NCT03437993 |
Not yet recruiting |
Recollect the Game: A Novel Treatment for Executive Functioning Deficits in Adults With ADHD |
|
- Other: Recollect, the game
- Other: Tetris
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change from baseline on The Behavioral Rating Inventory of Executive Functioning - Adult Version (BRIEF-A)
- Change from baseline on the Barkley Adult ADHD Rating Scale (BAARS-IV)
- Change from baseline on an App-based neuro-cognitive battery
|
40 |
All |
18 Years and older (Adult, Older Adult) |
NCT03437993 |
Recollect_ADHD |
|
October 1, 2018 |
March 31, 2019 |
June 1, 2019 |
February 19, 2018 |
April 10, 2018 |
|
- MacAnxiety Research Centre
Hamilton, Ontario, Canada
|
|
| 27 |
NCT02255565 |
Completed
Has Results |
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study |
|
- Drug: Very Low Dose Quillivant XR
- Drug: Low Dose Quillivant XR
- Drug: Moderate Dose Quillivant XR
|
Interventional
|
Phase 4 |
- Seattle Children's Hospital
- Pfizer
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- ADHD Rating Scale - IV
- Clinical Global Impressions-ADHD - Severity
- Clinical Global Impression - Improvement (CGI-I)
|
36 |
All |
5 Years to 16 Years (Child) |
NCT02255565 |
WI185890 |
|
September 2014 |
September 2016 |
October 2016 |
October 2, 2014 |
August 1, 2017 |
June 5, 2017 |
- Seattle Children's Hospital
Seattle, Washington, United States
|
|
| 28 |
NCT02780102 |
Unknown † |
Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD |
- Attention Deficit Hyperactivity Disorder
|
- Other: Cognitive-Motor Rehabilitation
- Drug: Ritalin
- Other: Active Control
|
Interventional
|
Not Applicable |
- Allameh Tabatabai University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Forward/backward digit span tasks from the Wechsler intelligence scale for children 4th edition (WISC-IV)
- Span board task from the Lumosity.com online brain training software
- Listening span task (L.SPAN)
- (and 6 more...)
|
48 |
Male |
9 Years to 12 Years (Child) |
NCT02780102 |
328/94/16090 |
ADHD |
September 2015 |
March 2016 |
September 2016 |
May 23, 2016 |
May 23, 2016 |
|
|
|
| 29 |
NCT01536210 |
Unknown † |
Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder) |
|
- Drug: YY-162
- Drug: Placebo
|
Interventional
|
Phase 3 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Korea-ADHD Rating scale
- IOWA conner's rating scale
- Clinical Global Impression(Severity and Improvement)
- (and 3 more...)
|
144 |
All |
6 Years to 15 Years (Child) |
NCT01536210 |
YY-162 (b) |
ADHD |
December 2011 |
August 2012 |
December 2012 |
February 20, 2012 |
February 20, 2012 |
|
- Hallym University Hospital
Anyang-si, Korea, Republic of - Inje University Ilsan Paik Hospital
Goyang-Si, Korea, Republic of - Seoul National University Hospital
Seoul, Korea, Republic of
|
|
| 30 |
NCT02778360 |
Recruiting |
Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder |
- Attention Deficit-Hyperactivity Disorder
|
- Device: Neurofeedback NFT
- Drug: Methylphenidate MPH
|
Interventional
|
Phase 1
Phase 2 |
- Mensia Technologies SA
- European Union H2020 SME Instrument
|
Industry / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change from Day 0 at Day 90 of the total score of the ADHD RS IV (Attention Deficit Hyperactivity Disorder Rating Scale IV)
- ADHD RS IV Inattention and Hyperactivity Sub-Scores
- Clinical responders
- (and 16 more...)
|
179 |
All |
7 Years to 13 Years (Child) |
NCT02778360 |
Newrofeed |
Newrofeed |
August 2016 |
September 2017 |
September 2017 |
May 19, 2016 |
April 5, 2017 |
|
- PSY Pluriel Centre europeen de psychologie medicale
Bruxelles, Belgium - Hôpital Erasme - Cliniques universitaires de Bruxelles
Bruxelles, Belgium - Centre Hospitalier Charles Perrens
Bordeaux, France - (and 9 more...)
|
|
| 31 |
NCT02420990 |
Recruiting |
Integrated Treatment for Adolescents With ADHD |
- ADHD
- Substance Use Disorders
|
- Behavioral: Medication Integration Protocol (MIP)
- Behavioral: Changing Academic Support in the Home for Adolescents with ADHD (CASH-AA)
|
Interventional
|
Not Applicable |
- The National Center on Addiction and Substance Abuse at Columbia University
- Patient-Centered Outcomes Research Institute
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Behavioral Symptoms: Conduct Problems (Number of times engaged in overt and covert delinquent acts during the assessment period.)
- Behavioral Symptoms: Substance Use Problems (Number of days used alcohol or illegal drugs per month during the assessment period.)
- Behavioral Symptoms: ADHD Symptoms (Number of ADHD symptoms endorsed.)
- Medication Uptake (Type and dose of current prescription and number of days that medication was taken during the assessment period.)
|
140 |
All |
12 Years to 18 Years (Child, Adult) |
NCT02420990 |
PCORI-1403-13704 |
CASALEAP IT2A |
April 2015 |
February 2018 |
March 2019 |
April 20, 2015 |
November 6, 2017 |
|
- The National Center on Addiction and Substance Abuse at Columbia University
New York, New York, United States
|
|
| 32 |
NCT03547843 |
Recruiting |
The Effects of Peer Co-led Educational Group Intervention for Adults With Attention-Deficit Hyperactivity Disorder |
- Attention Deficit Disorder With Hyperactivity
|
- Behavioral: Group-based education
- Behavioral: Waiting list
- Other: Standard treatment
|
Interventional
|
Not Applicable |
- Norwegian University of Science and Technology
- St. Olavs Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Change in client Satisfaction
- change in patient activation
- change in general self-efficacy
- (and 2 more...)
|
60 |
All |
18 Years to 67 Years (Adult, Older Adult) |
NCT03547843 |
2017/2405 REK |
ADHD |
May 31, 2018 |
December 2021 |
December 2021 |
June 6, 2018 |
August 28, 2018 |
|
- Tiller DPS
Trondheim, Norway
|
|
| 33 |
NCT01482026 |
Completed |
Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy |
|
- Other: ADHD Rating Scale-IV
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
|
- Evolution of the ADHD rating scale IV inattention subscore
- Evolution of the ADHD rating scale IV global score
- Evolution of the ADHD rating scale IV hyperactivity subscore
|
173 |
All |
6 Years to 16 Years (Child) |
NCT01482026 |
2011.682/25 |
|
November 2011 |
December 2015 |
December 2015 |
November 30, 2011 |
January 21, 2016 |
|
- Service de Neurologie pédiatrique, CHU d'Amiens
Amiens, France - Service de Neurologie Pédiatrique, CHU d'Angers
Angers, France - Service de Neurologie pédiatrique, CHU de Besançon
Besançon, France - (and 12 more...)
|
|
| 34 |
NCT01143701 |
Completed
Has Results |
Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care |
|
- Other: ADHD Collaborative
|
Interventional
|
Phase 4 |
- Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Care Provider)
- Primary Purpose: Health Services Research
|
- Parent-rated ADHD Symptoms
- Teacher-rated ADHD Symptoms
|
577 |
All |
6 Years to 11 Years (Child) |
NCT01143701 |
MH083665
1R01MH083665-01A2 |
|
May 2010 |
May 2015 |
June 2016 |
June 14, 2010 |
November 8, 2016 |
November 8, 2016 |
- Nationwide Childrens Hospital
Columbus, Ohio, United States
|
|
| 35 |
NCT02558790 |
Completed
Has Results |
L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD |
- Attention Deficit/Hyperactivity Disorder
- ADHD
|
- Drug: L-Threonic Acid Magnesium Salt (L-TAMS)
|
Interventional
|
Phase 2 |
- Massachusetts General Hospital
- Neurocentria, Inc.
|
Other / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in Adult ADHD Investigator Symptom Rating Scale (AISRS) Score
|
20 |
All |
18 Years to 55 Years (Adult) |
NCT02558790 |
2014-P-000528 |
|
March 2016 |
October 2017 |
October 2017 |
September 24, 2015 |
May 14, 2018 |
May 14, 2018 |
- Massachusetts General Hospital
Boston, Massachusetts, United States
|
|
| 36 |
NCT01431235 |
Completed |
CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders |
- Attention Deficit Hyperactivity Disorder
- Substance Use Disorders
|
- Behavioral: cognitive behavioral therapy for treating ADHD symptoms
|
Interventional
|
Not Applicable |
|
Industry / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- self reported ADHD symptoms
- Time Line Follow Back method
- Beck depression inventory
- (and 7 more...)
|
184 |
All |
18 Years to 60 Years (Adult) |
NCT01431235 |
10-130 |
|
August 2011 |
December 2016 |
December 2016 |
September 9, 2011 |
January 16, 2017 |
|
- Arkin
Amsterdam, Netherlands
|
|
| 37 |
NCT01104623 |
Unknown † |
ADHD - Voice Analysis, Vocal Acoustic Biomarkers in Attention Deficit Hyperactivity Disorder |
- Attention-Deficit/Hyperactivity Disorder
|
|
Observational
|
|
- Charite University, Berlin, Germany
- MediTECH Electronic GmbH
- AudioProfiling, Dr. Joerg Langner
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
|
400 |
All |
18 Years to 50 Years (Adult) |
NCT01104623 |
AiF KF2247401-AK9-1 |
ADHD |
April 2010 |
November 2012 |
December 2012 |
April 15, 2010 |
February 8, 2012 |
|
- Center for ADHD Research, Department of Psychiatry, Charite - University Medicine
Berlin, Germany
|
|
| 38 |
NCT03231800 |
Recruiting |
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. |
- Attention-Deficit Hyperactivity Disorder (ADHD)
|
- Drug: dasotraline
- Drug: Placebo
|
Interventional
|
Phase 3 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- change from baseline at Day 15 in ADHD symptoms as measured by mean SKAMP-Combined score obtained from an average of the 7 assessments collected across the 12-hour classroom day (12 to 24 hours postdose).
- Mean SKAMP-Combined score from the 7 assessments collected across the 12-hour classroom day (12 to 24 hours postdose) on Day 15
- SKAMP-Combined score at each of the assessment times (12-, 14-, 16-, 18-, 20-, 22-, and 24-hours postdose) during the classroom day on Day 15
- (and 15 more...)
|
100 |
All |
6 Years to 12 Years (Child) |
NCT03231800 |
SEP-360-311 |
|
July 31, 2017 |
November 17, 2018 |
November 17, 2018 |
July 27, 2017 |
July 4, 2018 |
|
- Avida Inc
Newport Beach, California, United States - Meridien Research
Bradenton, Florida, United States - Meridien Research
Maitland, Florida, United States - (and 5 more...)
|
|
| 39 |
NCT02700685 |
Recruiting |
Effect of Pycnogenol® on ADHD |
|
- Dietary Supplement: Pycnogenol
- Drug: Methylphenidate
- Other: Placebo
|
Interventional
|
Phase 3 |
- Nina Hermans
- Universiteit Antwerpen
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Summed ADHD score of the ADHD-Rating Scale as rated by teachers
- Summed ADHD score of the ADHD-Rating Scale as rated by parents
- Summed ADHD score of the Social-Emotional Questionnaire (SEQ) as rated by parents and teachers
- (and 19 more...)
|
144 |
All |
6 Years to 12 Years (Child) |
NCT02700685 |
Pycno 2015-14 |
|
September 1, 2017 |
May 2020 |
March 2021 |
March 7, 2016 |
August 28, 2018 |
|
- Universitaire Kinder- en Jeugdpsychiatrie
Borgerhout, Belgium - University Hospital Antwerp
Edegem, Belgium - University Hospital Ghent
Ghent, Belgium
|
|
| 40 |
NCT03324464 |
Recruiting |
Central Executive Training (CET) for ADHD |
|
- Behavioral: Central Executive Training: Working Memory
- Behavioral: Central Executive Training: Inhibitory Control
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- ADHD symptoms
- Working Memory
- Inhibitory control
- (and 2 more...)
|
250 |
All |
8 Years to 12 Years (Child) |
NCT03324464 |
R01MH115048 |
|
January 1, 2018 |
December 31, 2022 |
December 31, 2022 |
October 27, 2017 |
February 13, 2018 |
|
- Florida State University
Tallahassee, Florida, United States
|
|
| 41 |
NCT03104972 |
Recruiting |
Non-invasive Brain Stimulation for Pediatric ADHD |
|
- Device: tDCS
- Device: tRNS
- Device: sham
|
Interventional
|
Not Applicable |
- Hadassah Medical Organization
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- ADHD Rating Scale (ADHD-RS) parameters
- Wechsler Intelligence Scale for Children (WISC-IV)
- Behavior Rating Inventory of Executive Function (BRIEF)
- MOXO-Continuous Performance Test standardized attention test
|
100 |
All |
7 Years to 12 Years (Child) |
NCT03104972 |
HMO-17-0180 |
|
February 1, 2018 |
September 30, 2018 |
January 1, 2019 |
April 7, 2017 |
February 28, 2018 |
|
- The Neuro-Cognitive Center, Pediatric Division, Hadassah-Hebrew University Medical Center
Jerusalem, Mount Scopus, Israel
|
|
| 42 |
NCT01733680 |
Terminated
Has Results |
Amiloride Hydrochloride as an Effective Treatment for ADHD |
|
- Drug: amiloride
- Behavioral: Behavioral
|
Interventional
|
Early Phase 1 |
- State University of New York - Upstate Medical University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Improvement in CGI
- AISRS, Adult ADHD Investigator Rating Scale
- The Behavior Rating Inventory of Executive Function-Adult (BRIEF-A)
|
3 |
All |
18 Years to 55 Years (Adult) |
NCT01733680 |
320969 |
|
September 2012 |
September 2015 |
September 2015 |
November 27, 2012 |
July 20, 2018 |
July 20, 2018 |
- SUNY Upstate Medical University
Syracuse, New York, United States
|
|
| 43 |
NCT02271386 |
Active, not recruiting |
Educating and Supporting Primary Care Providers in the Implementation of Evidence-based Practices for ADHD |
- Attention Deficit Hyperactivity Disorder
|
- Behavioral: Supporting Practice for ADHD (SPA)
|
Interventional
|
Not Applicable |
- Children's Hospital of Philadelphia
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Composite Score for Provider Implementation of Evidence-Based Practices at the Visit Level
- Receipt of sufficient medication during intervention period
- Receipt of sufficient medication during follow-up period
- (and 13 more...)
|
5064 |
All |
5 Years to 12 Years (Child) |
NCT02271386 |
14-011189 |
|
November 2014 |
July 31, 2017 |
October 2017 |
October 22, 2014 |
October 31, 2017 |
|
- Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
|
|
| 44 |
NCT01272726 |
Completed |
Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women |
- Attention Deficit Hyperactivity Disorder
|
|
Observational
|
|
- Avera McKennan Hospital & University Health Center
|
Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- To determine if offering relative risk genotyping for ADHD, and educating around the genetic and environmental contributions to ADHD, may lead to greater health care acceptance in women who struggle with ADHD.
- To determine if women who think they have ADHD actually have ADHD.
|
60 |
Female |
18 Years to 59 Years (Adult) |
NCT01272726 |
ARI-1260-ADHD |
|
March 2009 |
December 2010 |
January 2011 |
January 10, 2011 |
June 1, 2012 |
|
- Avera Research Institute
Sioux Falls, South Dakota, United States
|
|
| 45 |
NCT01056016 |
Completed
Has Results |
Disseminating a Model Intervention to Promote Improved Attention-deficit Hyperactivity Disorder (ADHD) Care in the Community |
- Attention Deficit Hyperactivity Disorder
|
- Other: ADHD Collaborative
|
Interventional
|
Not Applicable |
- Children's Hospital Medical Center, Cincinnati
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Physician ADHD Practice Behavior
|
49 |
All |
Child, Adult, Older Adult |
NCT01056016 |
R21MH082714 |
|
July 2009 |
July 2010 |
December 2010 |
January 26, 2010 |
December 23, 2016 |
December 23, 2016 |
- Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio, United States
|
|
| 46 |
NCT02898532 |
Recruiting |
Children With ADHD and ADHD-like Symptoms and Target Shooting Sport in Danish Shooting Associations. |
|
- Behavioral: Educational programmes
|
Interventional
|
Not Applicable |
- University of Southern Denmark
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Teacher-rated ADHD-RS-IV.
- Qb-test.
- Parent-rated ADHD-RS-IV.
- (and 4 more...)
|
98 |
All |
10 Years to 14 Years (Child) |
NCT02898532 |
SDU-SUN-VEK20130134 |
|
January 2016 |
December 2017 |
December 2018 |
September 13, 2016 |
September 15, 2016 |
|
- Odense kommune
Odense, Region Syddanmark, Denmark
|
|
| 47 |
NCT03216512 |
Not yet recruiting |
Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD |
|
- Other: Use of Noise Cancelling Headphones
|
Interventional
|
Not Applicable |
- Duke University
- BOSE Corporation
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Participant)
- Primary Purpose: Other
|
- Change in CANTAB ADHD Battery
- Change in Academic Productivity Measures -Math
- Change in Subjective Reports of Experience
- Change in Academic Productivity Measures -Reading Comprehension
|
30 |
All |
6 Years to 17 Years (Child) |
NCT03216512 |
Pro00084739 |
|
August 2018 |
August 2019 |
August 2019 |
July 13, 2017 |
July 4, 2018 |
|
|
|
| 48 |
NCT02986672 |
Recruiting |
Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD) |
|
- Dietary Supplement: Calanus oil
- Other: Medical Paraffin
|
Interventional
|
Not Applicable |
- University Hospital of North Norway
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- ADHD rating scale by Russel Barkley
- BRIEF - Behavior Rating Inventory of Executive Function
- WISC - Wechsler Intelligence Scale for Children
- (and 3 more...)
|
330 |
All |
6 Years to 13 Years (Child) |
NCT02986672 |
ADHD_Kvernmo |
|
November 3, 2017 |
July 2020 |
July 2021 |
December 8, 2016 |
November 9, 2017 |
|
- University Hospital of North Norway
Tromsø, Troms, Norway
|
|
| 49 |
NCT03368573 |
Not yet recruiting |
QbTest Utility for Optimising Treatment in ADHD (QUOTA) |
|
|
Interventional
|
Not Applicable |
- Nottinghamshire Healthcare NHS Trust
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- SNAP-IV
- SDQ
- CHU9D
- (and 5 more...)
|
60 |
All |
6 Years to 17 Years (Child) |
NCT03368573 |
PB-PG-1215-20026 |
QUOTA |
December 2017 |
March 2019 |
March 2019 |
December 11, 2017 |
December 11, 2017 |
|
|
|
| 50 |
NCT03375021 |
Completed |
CX717 in the Treatment of Adult ADHD |
- Attention Deficit Hyperactivity Disorder
|
- Drug: CX717 200 mg
- Drug: CX717 800 mg
- Drug: Placebo
|
Interventional
|
Phase 2 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- ADHD-RS
- ADHD-RS subscales
- CGI-I
- (and 9 more...)
|
68 |
Male |
18 Years to 50 Years (Adult) |
NCT03375021 |
CX717-05-ADHD |
|
July 19, 2005 |
January 10, 2006 |
January 10, 2006 |
December 15, 2017 |
December 15, 2017 |
|
|
|
| 51 |
NCT01252446 |
Unknown † |
Children With ADHD Symptoms: Comorbid Conditions, Cognitive and Social Performance |
- Comorbid Conditions
- Social-demographic Profiles
|
|
Observational
|
|
- University of Bergen
- Helse Fonna
|
Other |
- Time Perspective: Retrospective
|
- Clinicians Manuals from Russell A. Barkley as Disruptive Behavior Disorders Rating Scale--Parent Form (Form 4), Disruptive Behavior Disorders Rating Scale--Teacher Form (Form 5) and Clinical Interview--Parent Report Form (Form 6)
- cognitive performance
|
187 |
All |
6 Years to 17 Years (Child) |
NCT01252446 |
219.04 REK
219.04(REK) |
NF ADHD |
September 2008 |
June 2010 |
December 2010 |
December 3, 2010 |
December 3, 2010 |
|
- Child and Adolescent Psychiatry Clinic Helse Fonna Haugesund
Haugesund, Rogaland, Norway
|
|
| 52 |
NCT02803229 |
Recruiting |
Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder |
- Cannabis Use Disorder
- Attention-deficit/Hyperactivity Disorder
|
- Drug: Adderall-XR
- Drug: Matched placebo
|
Interventional
|
Phase 2
Phase 3 |
- New York State Psychiatric Institute
- National Institute on Drug Abuse (NIDA)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Marijuana abstinence
- Reduction in ADHD symptoms
|
50 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT02803229 |
7280
U54DA037842-01 |
MJ-ADHD |
July 2016 |
June 2019 |
September 2019 |
June 16, 2016 |
May 16, 2018 |
|
- New York Psychiatric Institute
New York, New York, United States
|
|
| 53 |
NCT00966394 |
Completed |
Salivary Bacteria and Oral Health Status in Children With ADHD |
- Attention Deficit Hyperactivity Disorders
- Caries, Dental
- Xerostomia
|
|
Observational
|
|
- Hadassah Medical Organization
|
Other |
- Observational Model: Cohort
- Time Perspective: Cross-Sectional
|
|
150 |
All |
5 Years to 18 Years (Child, Adult) |
NCT00966394 |
adhd-hmo-ctil |
ADHD |
November 2009 |
May 2010 |
May 2010 |
August 26, 2009 |
May 26, 2010 |
|
- Hadassah school of dental medicine
Jerusalem, Israel
|
|
| 54 |
NCT02972086 |
Completed |
Improving Behavioral Health Care for Children With ADHD |
|
- Behavioral: Behavioral Parent Training (BPT)
|
Interventional
|
Not Applicable |
- New York University School of Medicine
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Attendance at BPT sessions
- Parenting Behavior
- ADHD and oppositional behavior will be measured by the IOWA Connors Rating Scale (IOWA-CRS)
- Parental Depressive Symptoms using Beck Depression Inventory-II
|
7 |
All |
18 Years and older (Adult, Older Adult) |
NCT02972086 |
16-01291 |
|
January 7, 2017 |
August 7, 2017 |
August 7, 2017 |
November 23, 2016 |
September 11, 2017 |
|
- New York University School of Medicine
New York, New York, United States
|
|
| 55 |
NCT00937469 |
Completed |
Social Skills Training and Standard Treatment Versus Standard Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) |
- ADHD
- Attention Deficit Hyperactivity Disorder
|
- Behavioral: Social skills training, parental tr. and standard tr.
- Other: Standard treatment
|
Interventional
|
Not Applicable |
- Region Zealand
- Zealand University Hospital
- Copenhagen Trial Unit, Center for Clinical Intervention Research
- Region Sjælland
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- ADHD core symptoms: measured by Conners 3 index: 'Hyperactivity- Impulsivity Scale' (teacher rated.)
- Aggressive behaviour: measured by Conners CBRS; subscale: 'Aggressive Behaviour Scale' (teacher rated).
- Emotional distress: measured by Conners CBRS: subscale: 'Emotional Distress Scale' (teacher rated).
- (and 4 more...)
|
55 |
All |
8 Years to 13 Years (Child) |
NCT00937469 |
SOSTRA-BU/REGIONSJ.1
Ethics C. no. SJ-85
Data p. agency no. DO50892 |
SOSTRA-ADHD |
August 2009 |
July 2011 |
July 2011 |
July 13, 2009 |
August 8, 2011 |
|
- Børnepsykiatrisk Ambulatorium, Børne- og Ungdomspsykiatrisk Afdeling, Region Sjælland
Holbæk, Denmark
|
|
| 56 |
NCT01684644 |
Completed |
A Controlled Study of Parent Training in the Treatment of ADHD in Young Children |
- Attention Deficit Hyperactivity Disorder
|
- Behavioral: New Forest Parenting Programme
- Behavioral: Treatment as usual
|
Interventional
|
Not Applicable |
- University of Aarhus
- Glostrup University Hospital, Copenhagen
- TrygFonden, Denmark
- Sygekassernes Helsefond
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- ADHD Rating Scale IV-Preschool Version
- Preschool ADHD-RS (Teacher completed) 18 items
- Strength and Difficulties Questionnaire (parent version)
- (and 4 more...)
|
164 |
All |
3 Years to 7 Years (Child) |
NCT01684644 |
7-10-1294 |
D'SNAPP |
September 2012 |
October 2015 |
December 2015 |
September 13, 2012 |
July 2, 2017 |
|
- Center for child and adolescent psychiatry
Risskov,, Aarhus, Denmark
|
|
| 57 |
NCT02041884 |
Unknown † |
CBT Through Internet and Smartphones for Adults With ADHD - a Randomized Controlled Trial |
|
- Behavioral: iCBT for Adults with ADHD
- Behavioral: Internet stress-reduction
- Other: Treatment as usual (TAU)/waiting list
|
Interventional
|
Not Applicable |
- Karolinska Institutet
- Stockholm County Council, Sweden
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change (from baseline) in ASRS- v 1.1
- Change (from baseline) in ADHD Rating Scale
- Change (from baseline) in EQ-5D
- (and 9 more...)
|
175 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT02041884 |
2014/333-31 |
Ad5 |
February 2014 |
February 2017 |
February 2017 |
January 22, 2014 |
September 5, 2016 |
|
- Internetpsykiatrienheten, Psykiatri Sydväst, SLSO
Stockholm, Sweden
|
|
| 58 |
NCT01329510 |
Completed |
Sleep and Nocturnal Melatonin in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
- Attention Deficit Hyperactivity Disorder
|
- Device: One-night polysomnographic recordings
|
Interventional
|
Not Applicable |
- Assaf-Harofeh Medical Center
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- polysomnographic parameters
- sleep questionnaire
|
19 |
All |
18 Years to 60 Years (Adult) |
NCT01329510 |
106/05 |
ADHD |
August 2005 |
December 2006 |
May 2007 |
April 6, 2011 |
April 6, 2011 |
|
- Assaf Harofeh Medical Center
Zrifin, Israel
|
|
| 59 |
NCT01795053 |
Recruiting |
Effects of Playtraining in ADHD Preschoolers on ADHD Symptoms and Play Persistence and Intensity |
|
- Behavioral: Experimental: playtraining
- Behavioral: Placebo open play session
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Care Provider)
- Primary Purpose: Treatment
|
- FBB-ADHD-V
- VBV-EL SUBSCALE play productivity and play-intensity
|
60 |
All |
3 Years to 6 Years (Child) |
NCT01795053 |
playtrainingADHD |
|
February 2012 |
July 2017 |
October 2017 |
February 20, 2013 |
March 15, 2017 |
|
- University of Cologne, clinic, department for child and adolescent psychtherapy and psychiatry
Cologne, Nordrhein-Westfahlen, Germany
|
|
| 60 |
NCT02253745 |
Completed |
Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD) |
|
- Drug: V81444
- Drug: Placebo
|
Interventional
|
Phase 1
Phase 2 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- ADHD-RS
- PERM-P
- Clinical Global Impression (CGI)
- Safety and Tolerability
|
31 |
All |
18 Years to 50 Years (Adult) |
NCT02253745 |
V81444-1CNS-01 |
|
July 2013 |
March 2014 |
April 2014 |
October 1, 2014 |
June 3, 2016 |
|
- Vince and Associates Clinical Research
Kansas City, Kansas, United States
|
|
| 61 |
NCT01243242 |
Completed
Has Results |
Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD) |
|
- Drug: Metadoxine (MG01CI)
|
Interventional
|
Phase 2 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Conners' Adult ADHD Rating Scales (CAARS™)
- Test of Variables of Attention (TOVA) (Change in ADHD Score From Screening to Visit 6)
- Adult ADHD Quality of Life (AAQoL)- Measuring Change in Total Score of AAQoL From Visit 1 to Visit 6
- Clinical Global Impression Scale (CGI-I)Score
|
120 |
All |
18 Years to 50 Years (Adult) |
NCT01243242 |
AL008 |
|
February 2011 |
August 2011 |
September 2011 |
November 18, 2010 |
April 20, 2012 |
April 18, 2012 |
- Cognitive Neurology unit Rambam Health Care Campus
Haifa, Israel - ADHD Unit, Geha Mental Health Center
Petah Tikva,, Israel
|
|
| 62 |
NCT03247530 |
Recruiting |
Evaluation of SPN-812 ER Low Dose in Children With ADHD |
|
- Drug: Placebo
- Drug: 100mg SPN-812 ER
- Drug: 200mg SPN-812 ER
|
Interventional
|
Phase 3 |
- Supernus Pharmaceuticals, Inc.
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Efficacy of SPN-812 ER assessed by ADHD -RS-5 Rating Scale
- Effect of SPN-812 ER assessed by Clinical Global Impression-Improvement (CGI-I)
- Effect of SPN-812 ER assessed by Conners 3 - Parent Rating Scale
- (and 5 more...)
|
432 |
All |
6 Years to 11 Years (Child) |
NCT03247530 |
812P301 |
|
October 20, 2017 |
September 14, 2018 |
September 20, 2018 |
August 11, 2017 |
September 11, 2018 |
|
- Harmonex Neuroscience Research
Dothan, Alabama, United States - Indago Research & Health Center, Inc.
Hialeah, Florida, United States - Advanced Clinical Research
Meridian, Idaho, United States - (and 4 more...)
|
|
| 63 |
NCT03595826 |
Recruiting |
Co Morbid Attention Deficit and Hyperactivity Disorder(ADHD) and Developmental Co Ordination Disorder (DCD) |
- Attention Deficit Disorder With Hyperactivity
- Developmental Coordination Disorder
|
- Drug: Neurostimulant pharmaceutical drugs
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Factorial Assignment
- Masking: Single (Investigator)
- Primary Purpose: Treatment
|
- Inattention, impulsivity and hyperactivity will be rated, using Conners rating scale.
- Motor co-ordination will be rated, using DCD questionnaire
|
250 |
All |
8 Years to 9 Years (Child) |
NCT03595826 |
Co Morbid ADHD and DCD |
|
May 2, 2018 |
August 2018 |
December 2018 |
July 23, 2018 |
August 21, 2018 |
|
- Escombe Primary School
Durban, Kzn, South Africa
|
|
| 64 |
NCT02327585 |
Unknown † |
Behavioral Intervention for Children With Attention Deficit Hyperactivity Disorder(ADHD) |
- Attention Deficit Hyperactivity Disorder
|
- Behavioral: A randomized controlled study of Executive Function training for children with ADHD
|
Interventional
|
Phase 1 |
- Min Chen
- Peking University
|
Other |
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Care Provider)
- Primary Purpose: Treatment
|
- change in ADHD-rating scale
- change in behavior rating scale of executive function
- cambridge Neuropsychological Test Automatic Battery
- Conners
|
80 |
All |
6 Years to 12 Years (Child) |
NCT02327585 |
2011-4024-04 |
|
June 2013 |
December 2015 |
December 2016 |
December 30, 2014 |
December 31, 2014 |
|
- Peking University Sixth Hospital/Institute of Mental Health
Beijing, China
|
|
| 65 |
NCT01883765 |
Completed |
Efficacy of Neurofeedback Training in Adults With ADHD |
- Attention Deficit Hyperactivity Disorder
|
- Behavioral: Neurofeedback active
- Behavioral: Neurofeedback sham
- Behavioral: Metacognitive Training
|
Interventional
|
Not Applicable |
- University Hospital Tuebingen
- German Research Foundation
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Changes in ADHD symptomatology
- Changes in co-morbid depression scores
- Changes in co-morbid anxiety scores
- (and 7 more...)
|
118 |
All |
18 Years to 60 Years (Adult) |
NCT01883765 |
SCHO 1448/2-1 |
|
February 2013 |
December 2015 |
November 2016 |
June 21, 2013 |
March 13, 2017 |
|
- Universität Tübingen
Tuebingen, Baden-Württemberg, Germany
|
|
| 66 |
NCT00573859 |
Completed
Has Results |
The Reinforcing Mechanisms of Smoking in Adult ADHD |
|
- Drug: ADHD medication
- Drug: Placebo
|
Interventional
|
Phase 1
Phase 2 |
- University of California, Irvine
|
Other |
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Basic Science
|
- The Effects of ADHD Medication Versus Placebo on Cotinine Levels
- The Interacting Effects of Smoking and Overnight Abstinence With ADHD Medication and Placebo on Continuous Performance Task (CPT) Errors of Omission.
- The Interacting Effects of Smoking and Abstinence With ADHD Medication and Placebo on Nicotine Withdrawal Measured by the Shiffman-Jarvik Withdrawal Questionnaire.
|
27 |
All |
18 Years to 45 Years (Adult) |
NCT00573859 |
2006-5156
NIH grant# DA018752 |
|
September 2006 |
June 2010 |
June 2010 |
December 14, 2007 |
November 7, 2011 |
November 7, 2011 |
- Department of Pediatrics
Irvine, California, United States
|
|
| 67 |
NCT01557595 |
Completed
Has Results |
Blue Wavelength Light-blocking Glasses in ADHD-Insomnia |
- Attention Deficit Hyperactivity Disorder
- Delayed Sleep Phase Type Circadian Rhythm Sleep Disorder
|
- Device: Polarized glasses designed to filter out blue light
|
Interventional
|
Not Applicable |
- University of Alabama at Birmingham
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Pittsburgh Sleep Quality Index (PSQI) at 2 Weeks After Baseline
|
22 |
All |
19 Years and older (Adult, Older Adult) |
NCT01557595 |
X110825016 |
ADHD |
September 2011 |
June 2012 |
June 2012 |
March 19, 2012 |
December 13, 2017 |
September 12, 2014 |
- University of Alabama at Birmingham
Birmingham, Alabama, United States
|
|
| 68 |
NCT01547702 |
Completed |
Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder |
- Attention Deficit Hyperactivity Disorder (ADHD)
|
- Behavioral: Teacher Help for ADHD
|
Interventional
|
Phase 2 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- The Impairment Rating Scale (IRS, Fabiano & Pelham, 2002)
- Knowledge of Attention Deficit Disorder Scale (KADDS; Sciutto, Terjesen, & Bender, 2000)
- Beliefs about Attention Deficit Hyperactivity Disorder (Kos, 2008)
- (and 8 more...)
|
116 |
All |
6 Years to 12 Years (Child) |
NCT01547702 |
NSHRF-44576 |
|
February 2012 |
May 2013 |
May 2013 |
March 8, 2012 |
March 28, 2014 |
|
- Dalhousie University
Halifax, Nova Scotia, Canada
|
|
| 69 |
NCT02062411 |
Completed |
A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder |
- Attention Deficit Disorder
|
- Behavioral: CBT only
- Behavioral: CBT with booster sessions
|
Interventional
|
Not Applicable |
- Peking University Sixth Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in ADHD Rating Scale
- Change in Conners Adult ADHD Rating Scale Self-report Screening Version (CAARS-S:SV)
- Change in Self-Rating Anxiety Scale (SAS)
- (and 7 more...)
|
108 |
All |
18 Years to 45 Years (Adult) |
NCT02062411 |
2013－9－23－3 |
|
October 2013 |
March 2016 |
March 2016 |
February 13, 2014 |
April 29, 2016 |
|
- Peking University Sixth Hospital
Beijing, Beijing, China
|
|
| 70 |
NCT03325881 |
Completed |
Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years |
- Attention Deficit Hyperactivity Disorder (ADHD)
|
- Drug: SHP465
- Drug: Placebo
|
Interventional
|
Phase 3 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Change From Baseline in Clinician-administered Attention-deficit/Hyperactivity Disorder Rating Scale-5 Child, Home Version (ADHD-RS-5) Total Score at Visit 6 (Week 4)
- Clinical Global Impression of Improvement (CGI-I) at Visit 6 (Week 4)
- Number of Participants With Treatment-Emergent Adverse Events (TEAEs)
- (and 6 more...)
|
89 |
All |
6 Years to 12 Years (Child) |
NCT03325881 |
SHP465-309 |
|
November 17, 2017 |
June 7, 2018 |
June 7, 2018 |
October 30, 2017 |
June 19, 2018 |
|
- Harmonex Neuroscience Research
Dothan, Alabama, United States - PEWMD, PA, ARCSM, PLLC, PRP, Inc.
Little Rock, Arkansas, United States - Advanced Research Center
Anaheim, California, United States - (and 38 more...)
|
|
| 71 |
NCT02226445 |
Completed |
Treatment Drop-out and Missed Appointments Among Adults With ADHD |
- Attention-Deficit/Hyperactivity Disorder
- Drop-out
- Non-adherence
|
- Other: Combined ADHD medication and psychosocial counseling
|
Observational
|
|
- University of Aarhus
- Central Denmark Region
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Treatment drop-out
- Missed appointments
|
153 |
All |
18 Years to 64 Years (Adult) |
NCT02226445 |
ADHD/DO/MA |
|
September 2010 |
January 2013 |
January 2013 |
August 27, 2014 |
August 27, 2014 |
|
- Psychiatric Research Unit West, Regional Psychiatric Services West
Herning, Denmark
|
|
| 72 |
NCT01660464 |
Completed |
Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) |
- Attention-Deficit/Hyperactivity Disorder
|
- Behavioral: CBT Based Self-help Workbook + Counseling Telepho
|
Interventional
|
Not Applicable |
- University of Cologne
- Eli Lilly and Company
|
Other / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Total score of the Symptom Checklist Attention-Deficit/Hyperactivity Disorder (SCL-ADHD, Döpfner, Görtz-Dorten & Lehmkuhl, 2008
- Strengths & Difficulties Questionnaire (SDQ)
- Quality of Life Questionnaire KINDL (Ravens-Sieberer & Bullinger, 2000)
|
50 |
All |
13 Years to 18 Years (Child, Adult) |
NCT01660464 |
ADHD-Team-03 |
|
January 2012 |
November 2013 |
November 2013 |
August 8, 2012 |
April 15, 2014 |
|
- Department of Child and Adolescent Psychiatry and Psychotherapy at the University of Cologne
Cologne, NRW, Germany
|
|
| 73 |
NCT01883817 |
Completed |
Effect of Omega-3 Fatty Acid on Cortical Function in ADHD |
- Attention Deficit Disorder
|
- Drug: DHA Omega-3
- Drug: Placebo
|
Interventional
|
Phase 3 |
- University of Cincinnati
- DSM Nutritional Products, Inc.
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- ADHD Symptoms
- Cortical Functional Integrity
|
30 |
All |
5 Years to 15 Years (Child) |
NCT01883817 |
2013-0199 |
|
September 2013 |
March 3, 2017 |
March 3, 2017 |
June 21, 2013 |
March 20, 2017 |
|
- University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
Cincinnati, Ohio, United States
|
|
| 74 |
NCT01752530 |
Completed |
Cognitive Training in Children With Attention Deficit/ Hyperactivity Disorder (ADHD) |
|
- Other: Computer program C8
- Other: Treatment as usual
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Cambridge Neuropsychological Test Automated Battery (CANTAB): Rapid Visual Information Processing probability of hit.
- Behavior Rating Inventory of Executive Functions (BRIEF)
- ADHD-Rating scale
- (and 2 more...)
|
70 |
All |
6 Years to 13 Years (Child) |
NCT01752530 |
S-20120096 |
|
February 2013 |
October 2015 |
September 2016 |
December 19, 2012 |
April 27, 2017 |
|
- Child and Adolescent Mental Health Services Aabenraa
Aabenraa, Denmark - Child and Adolescent Mental Health Services Augustenborg
Augustenborg, Denmark - Child and Adolescent Mental Health Services Kolding
Kolding, Denmark
|
|
| 75 |
NCT03247543 |
Recruiting |
Evaluation of SPN-812 ER High Dose in Children With ADHD |
|
- Drug: Placebo
- Drug: 200mg SPN-812 ER
- Drug: 400mg SPN-812 ER
|
Interventional
|
Phase 3 |
- Supernus Pharmaceuticals, Inc.
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Efficacy of SPN-812 ER assessed by ADHD-RS-5 Rating Scale
- Effect of SPN-812 ER assessed by Conners 3 Rating Scale
- Effect of SPN-812 ER assessed by 50% Responder Rate
- (and 4 more...)
|
300 |
All |
6 Years to 11 Years (Child) |
NCT03247543 |
812P303 |
|
October 31, 2017 |
October 1, 2018 |
October 1, 2018 |
August 11, 2017 |
September 6, 2018 |
|
- Alliance for Wellness
Long Beach, California, United States - Innovative Clinical Research, Inc
Lauderhill, Florida, United States - APG Research, LLC
Orlando, Florida, United States - (and 7 more...)
|
|
| 76 |
NCT01939353 |
Completed |
An Exploratory, Single-Blind Pilot Study Of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 SR in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder |
|
- Drug: EB-1020 SR
- Drug: Matching Placebo
|
Interventional
|
Phase 2 |
- Neurovance, Inc.
- Euthymics BioScience, Inc.
|
Industry |
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Change from Baseline-2 in Attention-Deficit Hyperactivity Disorder (ADHD) symptoms to Week 4 after investigational product administration, as assessed by the adult Attention-Deficit Hyperactivity Disorder Rating Scale (ADHD-RS-IV)
- Change from Baseline-2 on the adult ADHD-RS-IV
- Change from Baseline-2 on the Behavior Rating Inventory of Executive Function, Adult Version (BRIEF-A)
- (and 10 more...)
|
41 |
Male |
18 Years to 55 Years (Adult) |
NCT01939353 |
EB-1020-SR-ADHD-201 |
|
September 2013 |
February 2014 |
February 2014 |
September 11, 2013 |
November 5, 2015 |
|
- Florida Clinical Research Center, LLC.
Bradenton, Florida, United States - Florida Clinical Research Center, LLC.
Maitland, Florida, United States - Center for Psychiatry and Behavioral Medicine, Inc.
Las Vegas, Nevada, United States
|
|
| 77 |
NCT01932398 |
Completed |
A Study on the Inter-Hemispheric Alpha Ratio in Kids With ADHD (SHARK) |
|
|
Observational
|
|
|
Other |
- Observational Model: Case Control
- Time Perspective: Cross-Sectional
|
- Modualtion of alpha power
- Response time on covert attention task
- Standard deviation of response time on covert attention task
- (and 4 more...)
|
60 |
All |
84 Months to 95 Months (Child) |
NCT01932398 |
3016038.01 |
SHARK |
November 2011 |
January 2015 |
January 2015 |
August 30, 2013 |
January 21, 2015 |
|
- Donders Institute for Brain, Cognition and Behavior, Centre for Cognitive Neuroimaging
Nijmegen, Gelderland, Netherlands
|
|
| 78 |
NCT01012778 |
Completed |
Implementation of Climb Up Program for Children With Attention Deficit Hyperactivity Disorder (ADHD) and Dyslexia in a School in India |
- Attention Deficit Hyperactivity Disorder
- Dyslexia
|
- Behavioral: Climb Up ADHD and Dyslexia Program
|
Interventional
|
Phase 1
Phase 2 |
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Changes in ADHD scores using Vanderbilt
- Improvement in self-care as assessed by improvement in dental Decayed, Missing and Filled Teeth (DMFT) scores
- Improvement in speed and accuracy of reading samples for children with Dyslexia
|
76 |
All |
6 Years to 11 Years (Child) |
NCT01012778 |
NAJMDKV2007 |
ClimbUp |
May 2007 |
August 2015 |
August 2015 |
November 13, 2009 |
August 4, 2015 |
|
- MDKV Schools
Najibabad, UP, India
|
|
| 79 |
NCT01962181 |
Unknown † |
Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment |
- "Attention Deficit Hyperactivity Disorder"
|
- Drug: Ritalin
- Drug: Placebo
|
Interventional
|
Not Applicable |
- Hadassah Medical Organization
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Diagnostic
|
- Resting oscillation activity and Event-related-Potentials in Attention Deficit / Hyperactivity Disorder (ADHD) and healthy subjects.
|
40 |
All |
18 Years to 50 Years (Adult) |
NCT01962181 |
RE0379-HMO-STILL |
|
October 2013 |
December 2015 |
December 2015 |
October 14, 2013 |
October 14, 2013 |
|
- Hadassah Medical Center
Jerusalem, Israel
|
|
| 80 |
NCT02209116 |
Completed |
Assessing QbTest Utility in ADHD: A Randomised Controlled Trial |
- Attention Deficit Hyperactivity Disorder (ADHD)
|
|
Interventional
|
Not Applicable |
- University of Nottingham
- National Institute for Health Research, United Kingdom
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Diagnostic
|
- Number of clinic appointments until correct diagnosis confirmed
- Time to confirmation or exclusion of ADHD diagnosis (in days) and duration of clinic visits (in minutes).
|
267 |
All |
6 Years to 17 Years (Child) |
NCT02209116 |
CLAHRC-EM 14046 |
AQUA2 |
July 2014 |
June 2016 |
June 2016 |
August 5, 2014 |
June 22, 2016 |
|
- Central Manchester University Hospitals NHS Foundation Trust
Manchester, Greater Manchester, United Kingdom - Medway NHS Foundation Trust
Gillingham, Kent, United Kingdom - Bridgewater Community Healthcare NHS Trust
Wigan, Lancashire, United Kingdom - (and 6 more...)
|
|
| 81 |
NCT02136147 |
Enrolling by invitation |
ADHD Medication and Predictors of Treatment Outcome |
- Attention Deficit Disorder With Hyperactivity (ADHD)
|
- Drug: methylphenidate medication
- Drug: atomoxetine medication
- Drug: lisdexamphetamine medication
- Drug: guanfacine medication
|
Observational
|
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- change in SNAP-IV Teacher and Parent rating scale (Swanson, Nolan and Pelham ADHD Rating Scale)
- change in P-SEC (Pediatric Side Effects Checklist)
- change in C-GAS (Children´s global assessment scale)
- (and 8 more...)
|
2000 |
All |
6 Years to 18 Years (Child, Adult) |
NCT02136147 |
ADAPT
LS 1110-1339
SLS-309701 |
ADAPT |
June 2015 |
March 2019 |
|
May 12, 2014 |
March 22, 2017 |
|
- Division for Child and Adolescent Psychiatry in Stockholm
Stockholm, Stockholm county, Sweden
|
|
| 82 |
NCT01124708 |
Completed |
Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) |
|
- Drug: TC-5619-238
- Drug: Placebo
|
Interventional
|
Phase 2 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- CAARS-INV ADHD-rating scale
- CAARS-INV subscales
- CogState ADHD Battery
- (and 2 more...)
|
134 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT01124708 |
TC-5619-238-CRD-002
PRO-05619-CRD-002 |
|
May 2010 |
February 2011 |
February 2011 |
May 17, 2010 |
September 13, 2013 |
|
- Florida Clinical Research Center, LLC
Bradenton, Florida, United States - Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, United States - Fidelity Clinical Research, Inc
Lauderhill, Florida, United States - (and 13 more...)
|
|
| 83 |
NCT02407496 |
Completed |
Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD) |
- Attention Deficit Hyperactivity Disorder (ADHD)
|
- Other: Behavioral assessment and NAT EEG tests
|
Observational
|
|
- Think Now Incorporated
- University of California, Los Angeles
- National Institute of Mental Health (NIMH)
|
Industry / Other / NIH |
- Observational Model: Case Control
- Time Perspective: Cross-Sectional
|
- NAT Slow Fluctuation Measure
|
80 |
All |
18 Years to 40 Years (Adult) |
NCT02407496 |
TNI-NAT-1
R43MH099709 |
NAT-I |
June 2014 |
July 2015 |
September 2015 |
April 3, 2015 |
September 22, 2015 |
|
- UCLA Semel Institute
Los Angeles, California, United States
|
|
| 84 |
NCT00760747 |
Completed
Has Results |
Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD) |
- Attention Deficit Hyperactivity Disorder
|
|
Interventional
|
Phase 4 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change From Baseline in Attention Deficit Hyperactivity Disorder-Rating Scale (ADHD-RS-IV) Parent Version: Investigator Administered and Scored - Total Score at Week 10 Endpoint
- Change From Baseline in ADHD-RS-IV Parent Version: Investigator Administered and Scored - Total Score at Week 2 Endpoint
- Change From Baseline in Global Impression of Perceived Difficulties (GIPD) Rating Scale - Patient Total Score at Week 10 Endpoint
- (and 9 more...)
|
112 |
All |
6 Years to 16 Years (Child) |
NCT00760747 |
12305
B4Z-EW-LYFJ |
ADHD SWITCH |
September 2008 |
August 2010 |
September 2010 |
September 26, 2008 |
September 1, 2011 |
September 1, 2011 |
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Milton, Queensland, Australia - For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Zona Centro, Mexico - For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Fife, Scotland, United Kingdom - (and 3 more...)
|
|
| 85 |
NCT01862484 |
Completed
Has Results |
Neuroimaging of Diet in ADHD: Phase I |
- Attention Deficit Disorder With Hyperactivity
|
- Dietary Supplement: Restricted Diet
- Dietary Supplement: Ruse Diet
|
Interventional
|
Not Applicable |
- The University of Texas Health Science Center at San Antonio
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
|
40 |
All |
9 Years to 12 Years (Child) |
NCT01862484 |
R21MH09680 |
FTF |
May 2013 |
December 2014 |
December 2014 |
May 24, 2013 |
March 13, 2015 |
March 13, 2015 |
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
|
|
| 86 |
NCT01019252 |
Completed
Has Results |
Skills Training for Adolescents With ADHD |
- Attention Deficit Hyperactivity Disorder
|
- Behavioral: Cognitive Behavioral Therapy (CBT)
|
Interventional
|
Not Applicable |
- Massachusetts General Hospital
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Changes in Attention Deficit Hyperactivity Disorder (ADHD) Symptoms - Adolescent Report
- Attention Deficit Hyperactivity Disorder (ADHD) Symptom Severity - Clinician Rating
- Changes in Attention Deficit Hyperactivity Disorder (ADHD) Symptoms - Parent Report
|
66 |
All |
14 Years to 18 Years (Child, Adult) |
NCT01019252 |
R34MH083063
DDTR B4-TBI |
|
October 2009 |
August 2012 |
August 2012 |
November 25, 2009 |
July 31, 2018 |
July 31, 2018 |
- Massachusetts General Hospital
Boston, Massachusetts, United States
|
|
| 87 |
NCT02942030 |
Not yet recruiting |
Differences in Attentional Profile of Children Diagnosed With ADHD Versus Children Diagnosed With Other Mental Conditions |
|
- Other: Computerized assesment battery
|
Observational
|
|
- Clalit Health Services
- Tel Aviv University
|
Other |
- Observational Model: Cohort
- Time Perspective: Cross-Sectional
|
- diagnosis - after psychiatric evaluation
- attentional computerized profile
- correlations - clinical diagnosis and attentional profile
|
70 |
All |
8 Years to 12 Years (Child) |
NCT02942030 |
000816-com2 |
|
November 2016 |
November 2017 |
November 2017 |
October 21, 2016 |
November 29, 2016 |
|
- Mishmar Ha'Am Clinic
Jerusalem, Israel
|
|
| 88 |
NCT01404273 |
Completed |
Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder |
|
- Behavioral: Meditation/Relaxation Response Training
|
Interventional
|
Not Applicable |
- Massachusetts General Hospital
- Centers for Disease Control and Prevention
|
Other / U.S. Fed |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in functional magnetic resonance imaging (fMRI) activation from baseline after a 6-week intervention
|
12 |
All |
18 Years to 49 Years (Adult) |
NCT01404273 |
2009P002052 |
ADHD |
September 2009 |
September 2011 |
September 2011 |
July 28, 2011 |
July 31, 2013 |
|
- Benson-Henry Institute, 151 Merrimac St, 4th Floor
Boston, Massachusetts, United States
|
|
| 89 |
NCT02430896 |
Recruiting |
Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD |
- Attention Deficit Disorder With Hyperactivity
|
- Drug: Methylphenidate (MPH)
- Drug: Atomoxetine
|
Observational
|
|
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Wide genome analysis regarding genetic polymorphisms as predictors of treatment response in Attention-Deficit/Hyperactivity Disorder(ADHD).
- Neuroimaging analysis as predictors of treatment response in Attention-Deficit/Hyperactivity Disorder(ADHD).
- Drug effectiveness is assessed using ADHD rating scale, CGI -S (Clinical Global Impression - Severity scale) and CGI-I (Clinical Global Impression - Improvement scale).
- (and 2 more...)
|
600 |
All |
6 Years to 12 Years (Child) |
NCT02430896 |
S2013-0373-0014 |
|
February 2015 |
December 2018 |
February 2020 |
April 30, 2015 |
January 10, 2018 |
|
- Asan Medical Center
Seoul, Korea, Republic of
|
|
| 90 |
NCT01649232 |
Completed
Has Results |
ADHD Electrophysiological Subtypes and Implications in Transcranial Direct-current Stimulation |
|
|
Interventional
|
Phase 3 |
- Spanish Foundation for Neurometrics Development
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Factorial Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Clinical Assessment (Amen Questionnaire)
- Event-related Potentials Amplitude (ERPs)
- Event-related Potentials Latency (ERPs)
- (and 2 more...)
|
60 |
All |
8 Years to 68 Years (Child, Adult, Older Adult) |
NCT01649232 |
vpradtdcs0102012 |
tdcs&adhd |
June 2012 |
December 2012 |
December 2012 |
July 25, 2012 |
May 5, 2014 |
April 21, 2014 |
- Murcia University, Psychology School
Murcia, Spain
|
|
| 91 |
NCT02801604 |
Recruiting |
Attentin® in Children and Adolescents With ADHD - A Non-interventional Study |
- Attention Deficit Hyperactivity Disorder
|
|
Observational
|
|
- Medice Arzneimittel Pütter GmbH & Co KG
- University Hospital, Essen
|
Industry / Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- ADHD classification
- ADHD classification subgroup: Age
- ADHD classification subgroup: Dose under MPH therapy
- (and 18 more...)
|
500 |
All |
6 Years to 215 Months (Child) |
NCT02801604 |
Attention |
Attention |
June 2016 |
February 2019 |
February 2019 |
June 16, 2016 |
October 25, 2017 |
|
- Child and Adolescent Psychiatry, University of Medicine
Mainz, Germany
|
|
| 92 |
NCT01978769 |
Completed |
The Effect of Physical Effort in the Decision Making Process of Preadolescents With ADHD |
|
|
Observational
|
|
- Shaare Zedek Medical Center
|
Other |
- Observational Model: Case Control
- Time Perspective: Cross-Sectional
|
- The number of "low effort" choices of the ADHD participants compared to the number of "low effort" choices of the control participants
|
60 |
All |
11 Years to 13 Years (Child) |
NCT01978769 |
effortdiscounting.ctil |
|
November 2014 |
April 2015 |
April 2015 |
November 8, 2013 |
September 9, 2015 |
|
- Shaarei Zedek Medical Center
Jerusalem, Israel
|
|
| 93 |
NCT01727414 |
Completed
Has Results |
Attention Deficit Disorder Medication Response Study |
- ADHD - Inattentive Type
- ADHD - Combined Type
|
- Drug: OROS-Methylphenidate and placebo for inattentive type pts
- Drug: OROS-Methylphenidate and placebo for combined type pts
|
Interventional
|
Phase 4 |
- Children's Hospital Medical Center, Cincinnati
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
|
171 |
All |
7 Years to 11 Years (Child) |
NCT01727414 |
ADDMedStudy
K23MH083881 |
|
June 2006 |
July 2013 |
July 2014 |
November 16, 2012 |
July 18, 2017 |
July 18, 2017 |
- Children's Hospital Medical Center
Cincinnati, Ohio, United States
|
|
| 94 |
NCT02734693 |
Completed |
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. |
- Attention-Deficit Hyperactivity Disorder (ADHD)
|
- Drug: dasotraline 4mg
- Other: Placebo
|
Interventional
|
Phase 3 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Change from baseline at Day 15 in ADHD symptoms as measured by mean SKAMP-Combined score obtained from an average of the 7 assessments collected across the 12-hour classroom day (12 to 24 hours postdose).
- Mean SKAMP-Combined score from the 7 assessments collected across the 12-hour classroom day (12 to 24 hours postdose) on Day 15
- SKAMP-Combined score at each of the assessment times (12-, 14-, 16-, 18-, 20-, 22-, and 24-hours postdose) during the classroom day on Day 15
- (and 16 more...)
|
130 |
All |
6 Years to 12 Years (Child) |
NCT02734693 |
SEP360-305 |
|
April 2016 |
February 2017 |
February 2017 |
April 12, 2016 |
January 10, 2018 |
|
- Avida Inc
Newport Beach, California, United States - Meridien Research
Bradenton, Florida, United States - Florida Clinical Research Center, LLC
Maitland, Florida, United States - (and 2 more...)
|
|
| 95 |
NCT01819259 |
Active, not recruiting |
Nicotine, Non-Smokers With and Without ADHD, and Genetics Study |
|
- Drug: Nicotine nasal spray
- Drug: Placebo
|
Interventional
|
Phase 1 |
- Scott Kollins, PhD
- National Institute on Drug Abuse (NIDA)
- Duke University
|
Other / NIH |
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Masking: Single (Participant)
- Primary Purpose: Basic Science
|
- Change in cognitive performance.
- Differences in Subjective Effects.
- Change in Physiological Effects.
- (and 2 more...)
|
150 |
All |
18 Years to 25 Years (Adult) |
NCT01819259 |
Pro00037792
1R01DA033080 |
NNSG |
January 2013 |
October 2018 |
April 2019 |
March 27, 2013 |
August 24, 2018 |
|
- Duke Child and Family Study Center
Durham, North Carolina, United States
|
|
| 96 |
NCT02560454 |
Recruiting |
Cognitive Training in Children With Attention Deficit Hyperactivity Disorder (ADHD) |
- Attention Deficit Hyperactivity Disorder (ADHD)
|
- Behavioral: Cogmed
- Behavioral: Presco
|
Interventional
|
Not Applicable |
- Assistance Publique - Hôpitaux de Paris
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- The ADHD Rating Scale IV (ADHD RS)
- ADHD Scale
- TEA-Ch and Continuous Performance Test
- (and 2 more...)
|
90 |
All |
8 Years to 12 Years (Child) |
NCT02560454 |
K140706 |
TDAHEC2 |
January 2016 |
July 2018 |
July 2018 |
September 25, 2015 |
March 2, 2018 |
|
|
|
| 97 |
NCT01458340 |
Completed |
A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
- Attention-Deficit/Hyperactivity Disorder
- ADHD
|
- Drug: TD-9855
- Drug: Placebo
|
Interventional
|
Phase 2 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Adult ADHD Investigator Symptom Rating Scale (AISRS)
- Barkley Deficits in Executive Functioning Scale-short form: self report (BDEFS-SF:Self-Report)
|
285 |
All |
18 Years to 45 Years (Adult) |
NCT01458340 |
0085 |
|
December 2011 |
October 2013 |
November 2013 |
October 24, 2011 |
September 13, 2018 |
|
- Florida Clinical Research Center, LLC
Bradenton, Florida, United States - Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, United States - Florida Clinical Research Center
Maitland, Florida, United States - (and 14 more...)
|
|
| 98 |
NCT02248948 |
Completed |
Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children |
- Attention Deficit Hyperactivity Disorder (ADHD)
|
- Dietary Supplement: Omega-3 Fatty Acids
- Dietary Supplement: Medium Chain Triglycerides
|
Interventional
|
Phase 4 |
- Laboratorios Ordesa
- Clever Instruments S.L.
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Improvement in clinical symptoms of ADHD
- Changes in neuropsychological outcomes
- Changes in emotional outcomes
- (and 2 more...)
|
231 |
All |
6 Years to 11 Years (Child) |
NCT02248948 |
ECOMEGA-TDAH-014
2013-004638-14 |
ECOMEGA |
September 2014 |
July 2016 |
July 2016 |
September 25, 2014 |
August 8, 2016 |
|
- Centro Médico Teknon
Barcelona, Spain
|
|
| 99 |
NCT02788851 |
Active, not recruiting |
The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
- Attention Deficit Hyperactivity Disorder (ADHD)
|
- Drug: Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine
- Behavioral: Aerobic Exercise
|
Interventional
|
Not Applicable |
- McGill University Health Center
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Self-reported ADHD symptoms (measured via Barkley's Current ADHD Symptoms Scale) - Change from baseline
- Depression symptoms (via the Beck Depression Inventory) - Change from baseline
- Anxiety Symptoms (measured via the Beck Anxiety Inventory) - Change from baseline
- (and 5 more...)
|
70 |
All |
18 Years to 60 Years (Adult) |
NCT02788851 |
MUHC-15-226 |
|
April 2016 |
December 2018 |
December 2018 |
June 2, 2016 |
August 15, 2018 |
|
- Montreal Children's Hospital
Montreal, Quebec, Canada
|
|
| 100 |
NCT02204410 |
Completed
Has Results |
Omega-3 Supplementation to ADHD Medication in Children |
- Attention Deficit Hyperactivity Disorder
- Deficient Emotional Self-Regulation
|
- Dietary Supplement: Omega-3 Fatty Acid
- Drug: ADHD Medication
|
Interventional
|
Phase 4 |
- Massachusetts General Hospital
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Emotional Control Subscale of the Behavior Rating Inventory of Executive Function - Parent Form (BRIEF-Parent)
- Clinical Global Impression (CGI) Improvement for Deficient Emotional Self-Regulation (DESR)
|
21 |
All |
6 Years to 17 Years (Child) |
NCT02204410 |
2014-P-000015 |
|
July 2014 |
May 2016 |
August 2016 |
July 30, 2014 |
June 29, 2017 |
June 29, 2017 |
- Massachusetts General Hospital
Boston, Massachusetts, United States
|
|
Create an RSS feed from your search for:
Download the search results for: